Showing results (91-100 of 273) with videos related to

Sort By:
Pageof 28
Cancer Chemotherapy and Pharmacology|November 8, 2005
Hormone treatment for prostate cancer: current issues and future directionsTomohiko Ichikawa, Hiroyoshi Suzuki, Takeshi Ueda, et al.
Hinyokika Kiyo. Acta Urologica Japonica|July 17, 2007
[The clinical efficacy of SNRI milnacipran in the treatment of hot flushes with prostate cancer hormonally treated]Hiroyoshi Suzuki, Akira Komiya, Satoko Kojima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 3, 2023
[Eight Cases of Breast Cancer That Relapsed More Than Ten Years after Initial Treatment]Atsushi Yoshimura, Takeshi Ueda, Tetsuya Tanaka, et al.
International Journal of Pharmaceutics|May 10, 2011
Evaluation of the physicochemical characteristics of crospovidone that influence solid dispersion preparationSayaka Nakanishi, Makiko Fujii, Yuka Sugamura, et al.
Medicine|October 8, 2021
Changes in serum uric acid levels as a predictor of future decline in renal function in older adults with type 2 diabetesYusuke Shibata, Masanori Yamazaki, Junichiro Kitahara, et al.
Chemical & Pharmaceutical Bulletin|February 8, 2011
Effect of particle size of drug on conversion of crystals to an amorphous state in a solid dispersion with crospovidoneYuka Sugamura, Makiko Fujii, Sayaka Nakanishi, et al.
Drug Development and Industrial Pharmacy|April 28, 2006
Fluidity and tableting characteristics of a powder solid dispersion of the low melting drugs ketoprofen and ibuprofen with crospovidoneYusuke Shibata, Makiko Fujii, Shinobu Noda, et al.
Journal of Pharmaceutical Sciences|December 1, 2006
Effect of characteristics of compounds on maintenance of an amorphous state in solid dispersion with crospovidoneYusuke Shibata, Makiko Fujii, Makiko Kokudai, et al.
Pharmaceutical Development and Technology|May 21, 2013
Effect of storage conditions on the recrystallization of drugs in solid dispersions with crospovidoneYusuke Shibata, Makiko Fujii, Ayako Suzuki, et al.
Pageof 28